Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary

Takayo Ota, Amy C. Clayton, Douglas M. Minot, Viji Shridhar, Lynn C. Hartmann, C. Blake Gilks, Jeremy R. Chien

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Minichromosome maintenance protein 7 (MCM7) is involved in replicative licensing and synthesis of DNA. It was previously identified as an overexpressed gene in high-grade serous carcinomas compared with serous borderline tumors of the ovary in cDNA microarray studies. In this study, we sought to validate MCM7 expression in 342 ovarian tumors on tissue microarrays. MCM7 expression was quantified as the MCM7 labeling index, and it was independently generated by two methods: a score provided by manual review of each sample by a pathologist observer and by an automated cellular imaging system. Analyses of MCM7 scores indicated a high degree of concordance and distribution between the observer- and machine-generated MCM7 labeling indexes. MCM7 expression was significantly higher in high-grade serous carcinomas than in serous borderline tumors or other histological subtypes of ovarian cancer. For both observer- and machine-derived scores, univariate analyses indicated the significant association of a high MCM7 labeling index with better progression-free survival in high-grade serous carcinomas. These results suggest the clinical importance of MCM7 expression in high-grade serous carcinomas of the ovary and the need for further evaluation of MCM7 as a potential prognostic factor in ovarian cancer.

Original languageEnglish (US)
Pages (from-to)277-287
Number of pages11
JournalModern Pathology
Volume24
Issue number2
DOIs
StatePublished - Feb 1 2011
Externally publishedYes

Fingerprint

Minichromosome Maintenance Proteins
Disease-Free Survival
Ovary
Carcinoma
Ovarian Neoplasms
Neoplasms
Licensure
Oligonucleotide Array Sequence Analysis

Keywords

  • immunohistochemistry
  • MCM7
  • ovarian cancer

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary. / Ota, Takayo; Clayton, Amy C.; Minot, Douglas M.; Shridhar, Viji; Hartmann, Lynn C.; Gilks, C. Blake; Chien, Jeremy R.

In: Modern Pathology, Vol. 24, No. 2, 01.02.2011, p. 277-287.

Research output: Contribution to journalArticle

Ota, Takayo ; Clayton, Amy C. ; Minot, Douglas M. ; Shridhar, Viji ; Hartmann, Lynn C. ; Gilks, C. Blake ; Chien, Jeremy R. / Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary. In: Modern Pathology. 2011 ; Vol. 24, No. 2. pp. 277-287.
@article{028bfa79ae27444b87e66482b33cab96,
title = "Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary",
abstract = "Minichromosome maintenance protein 7 (MCM7) is involved in replicative licensing and synthesis of DNA. It was previously identified as an overexpressed gene in high-grade serous carcinomas compared with serous borderline tumors of the ovary in cDNA microarray studies. In this study, we sought to validate MCM7 expression in 342 ovarian tumors on tissue microarrays. MCM7 expression was quantified as the MCM7 labeling index, and it was independently generated by two methods: a score provided by manual review of each sample by a pathologist observer and by an automated cellular imaging system. Analyses of MCM7 scores indicated a high degree of concordance and distribution between the observer- and machine-generated MCM7 labeling indexes. MCM7 expression was significantly higher in high-grade serous carcinomas than in serous borderline tumors or other histological subtypes of ovarian cancer. For both observer- and machine-derived scores, univariate analyses indicated the significant association of a high MCM7 labeling index with better progression-free survival in high-grade serous carcinomas. These results suggest the clinical importance of MCM7 expression in high-grade serous carcinomas of the ovary and the need for further evaluation of MCM7 as a potential prognostic factor in ovarian cancer.",
keywords = "immunohistochemistry, MCM7, ovarian cancer",
author = "Takayo Ota and Clayton, {Amy C.} and Minot, {Douglas M.} and Viji Shridhar and Hartmann, {Lynn C.} and Gilks, {C. Blake} and Chien, {Jeremy R.}",
year = "2011",
month = "2",
day = "1",
doi = "10.1038/modpathol.2010.202",
language = "English (US)",
volume = "24",
pages = "277--287",
journal = "Modern Pathology",
issn = "0893-3952",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Minichromosome maintenance protein 7 as a potential prognostic factor for progression-free survival in high-grade serous carcinomas of the ovary

AU - Ota, Takayo

AU - Clayton, Amy C.

AU - Minot, Douglas M.

AU - Shridhar, Viji

AU - Hartmann, Lynn C.

AU - Gilks, C. Blake

AU - Chien, Jeremy R.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Minichromosome maintenance protein 7 (MCM7) is involved in replicative licensing and synthesis of DNA. It was previously identified as an overexpressed gene in high-grade serous carcinomas compared with serous borderline tumors of the ovary in cDNA microarray studies. In this study, we sought to validate MCM7 expression in 342 ovarian tumors on tissue microarrays. MCM7 expression was quantified as the MCM7 labeling index, and it was independently generated by two methods: a score provided by manual review of each sample by a pathologist observer and by an automated cellular imaging system. Analyses of MCM7 scores indicated a high degree of concordance and distribution between the observer- and machine-generated MCM7 labeling indexes. MCM7 expression was significantly higher in high-grade serous carcinomas than in serous borderline tumors or other histological subtypes of ovarian cancer. For both observer- and machine-derived scores, univariate analyses indicated the significant association of a high MCM7 labeling index with better progression-free survival in high-grade serous carcinomas. These results suggest the clinical importance of MCM7 expression in high-grade serous carcinomas of the ovary and the need for further evaluation of MCM7 as a potential prognostic factor in ovarian cancer.

AB - Minichromosome maintenance protein 7 (MCM7) is involved in replicative licensing and synthesis of DNA. It was previously identified as an overexpressed gene in high-grade serous carcinomas compared with serous borderline tumors of the ovary in cDNA microarray studies. In this study, we sought to validate MCM7 expression in 342 ovarian tumors on tissue microarrays. MCM7 expression was quantified as the MCM7 labeling index, and it was independently generated by two methods: a score provided by manual review of each sample by a pathologist observer and by an automated cellular imaging system. Analyses of MCM7 scores indicated a high degree of concordance and distribution between the observer- and machine-generated MCM7 labeling indexes. MCM7 expression was significantly higher in high-grade serous carcinomas than in serous borderline tumors or other histological subtypes of ovarian cancer. For both observer- and machine-derived scores, univariate analyses indicated the significant association of a high MCM7 labeling index with better progression-free survival in high-grade serous carcinomas. These results suggest the clinical importance of MCM7 expression in high-grade serous carcinomas of the ovary and the need for further evaluation of MCM7 as a potential prognostic factor in ovarian cancer.

KW - immunohistochemistry

KW - MCM7

KW - ovarian cancer

UR - http://www.scopus.com/inward/record.url?scp=79551646236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551646236&partnerID=8YFLogxK

U2 - 10.1038/modpathol.2010.202

DO - 10.1038/modpathol.2010.202

M3 - Article

C2 - 21076460

AN - SCOPUS:79551646236

VL - 24

SP - 277

EP - 287

JO - Modern Pathology

JF - Modern Pathology

SN - 0893-3952

IS - 2

ER -